Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis. Li, Y., Delcher, C., Brown, J. D., Wei, Y., Reisfield, G. M., & Winterstein, A. G. Drug and Alcohol Dependence, 202:172–177, Elsevier BV, September, 2019.
Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis [link]Paper  doi  bibtex   
@article{Li2019,
  doi = {10.1016/j.drugalcdep.2019.05.025},
  url = {https://doi.org/10.1016/j.drugalcdep.2019.05.025},
  year = {2019},
  month = sep,
  publisher = {Elsevier {BV}},
  volume = {202},
  pages = {172--177},
  author = {Yan Li and Chris Delcher and Joshua D. Brown and Yu-Jung Wei and Gary M. Reisfield and Almut G. Winterstein},
  title = {Impact of Schedule {IV} controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis},
  journal = {Drug and Alcohol Dependence}
}

Downloads: 0